(Q33901636)

29 July 2017

1 reference

title

New animal models for Parkinson's disease (English)

1 reference

29 July 2017

1 reference

Dawson TM

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

101

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

115-118

1 reference

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

NOS knockouts and neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Reversing neurodegeneration: a promise unfolds

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Autosomal dominant Parkinson's disease and alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980629-7

7 January 2021

10.1016/S0092-8674(00)80629-7

Identifiers

DOI

1 reference

29 July 2017

1 reference